Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer Therapy
NCT03355079
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class
Stopped
Low Patient Recruitment
Conditions
Cancer-related Malnutrition
Interventions
DRUG:
SmofKabiven® E
Sponsor
Fresenius Kabi